Who We Are
We are a South African pharmaceutical company established in 2020, bringing new drugs and biologicals to the local market.
Innovation
for Patients
Biomab is a pharmaceutical company that is committed to providing faster and broader access to innovation for patients in Southern Africa. We achieve this through our unique, legal, and ethical solutions, which include expanding the range of multinational innovator products in the region.
National Field Force
Biomab has an industry leading specialist team of representatives and medical personnel with national reach. Our team has established relationships with customers in both the Public and Private sectors. We actively call on practitioners in the spheres of Oncology, Haematology, General and Specialised Medicine.
BIOMAB VALUES
Patient-Centricity
Integrity
Expertise
Innovation
Collaboration
Impact
Market Leaders
Biomab is a market leader in Southern Africa. We presently have marketing authorisation for Roche and Helsinn products and are a member of the Innovative Pharmaceutical Association of South Africa. Biomab works closely with oncologists and is a DSP to a national managed healthcare company, which is 74% owned by oncologists.
Biomab’s commitment to providing access to innovation for patients in Southern Africa is evident in our unique, legal, and ethical solutions. Our expertise in the pharmaceutical industry, including our highly trained national representative team and regulatory department, allows us to expand the range of multinational innovator products in the region.
Transforming Healthcare
Biomab is your partner in expanding access to innovative medications. Whether you’re a patient, healthcare provider, or industry stakeholder, we’re here to make a difference.